PARK ROAD GROUP PRACTICE — All Prescriptions & Medications — Page 9
Practice Code: H81069 | CAMBERLEY, GU15 2NN
Showing results 401-450 of 755
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Sodium picosulfate | 65 | 14.9K | £1.1K | +79.1% ▲ |
| Terbutaline sulphate | 65 | 94 | £742 | +19.9% ▲ |
| Codeine phosphate | 65 | 20.5K | £258 | +352.9% ▲ |
| Sotalol hydrochloride | 64 | 5,796 | £164 | -9.0% ▼ |
| Nebivolol | 63 | 2,660 | £317 | -40.6% ▼ |
| Cinnarizine | 63 | 4,698 | £213 | +34.6% ▲ |
| Other toiletry preparations | 62 | 30.7K | £633 | +45.2% ▲ |
| Dipyridamole | 61 | 5,742 | £1.7K | +137.6% ▲ |
| Oxytetracycline | 61 | 5,272 | £1.9K | +136.2% ▲ |
| Leuprorelin acetate | 61 | 62 | £12.1K | +31.6% ▲ |
| Ketone blood testing reagents | 60 | 1,000 | £1.0K | -11.3% ▼ |
| Ergocalciferol | 60 | 632 | £281 | +258.4% ▲ |
| Fluvastatin sodium | 59 | 3,024 | £601 | +155.1% ▲ |
| 59 | 1,982 | £5.5K | +74.7% ▲ | |
| 59 | 2,610 | £3.7K | +261.5% ▲ | |
| Ciprofloxain/dexameth | 58 | 325 | £379 | +88.9% ▲ |
| Ivermectin | 58 | 2,685 | £1.6K | +172.8% ▲ |
| 58 | 138 | £2.8K | +320.0% ▲ | |
| Isophane insulin | 57 | 380 | £1.6K | -46.0% ▼ |
| Dexamethasone | 57 | 1,732 | £220 | +82.9% ▲ |
| 57 | 1,210 | £2.5K | -16.8% ▼ | |
| 56 | 12.0K | £547 | +522.9% ▲ | |
| Alverine citrate | 55 | 6,166 | £473 | +32.9% ▲ |
| Sodium citrate (Rectal) | 55 | 418 | £280 | +298.6% ▲ |
| Norethisterone | 55 | 2,950 | £498 | +13.4% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 55 | 222.5K | £4.5K | -21.4% ▼ |
| Ipratropium bromide | 54 | 417 | £378 | +87.9% ▲ |
| Diclofenac sodium | 54 | 3,150 | £2.3K | +125.3% ▲ |
| 54 | 2,140 | £1.6K | +250.5% ▲ | |
| Naratriptan hydrochloride | 53 | 564 | £110 | +102.7% ▲ |
| Anastrozole | 53 | 2,903 | £107 | -41.8% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 53 | 32.4K | £499 | +131.3% ▲ |
| Pyridostigmine bromide | 53 | 12.6K | £943 | +209.6% ▲ |
| Adapalene | 53 | 2,655 | £922 | +142.1% ▲ |
| 53 | 3,924 | £232 | +41.9% ▲ | |
| Rabeprazole sodium | 52 | 2,408 | £301 | +0.8% vs avg |
| Pioglitazone hydrochloride | 52 | 2,100 | £79 | -41.2% ▼ |
| 52 | 9,155 | £383 | -76.0% ▼ | |
| Tapentadol | 51 | 3,752 | £3.5K | +23.9% ▲ |
| Tacrolimus | 51 | 3,500 | £6.6K | +90.7% ▲ |
| Meloxicam | 51 | 1,915 | £55 | -22.9% ▼ |
| Indacaterol/glycopyrronium | 50 | 1,710 | £1.8K | +10.7% ▲ |
| Erythromycin | 50 | 3,908 | £1.0K | +44.3% ▲ |
| Valaciclovir | 50 | 2,407 | £3.6K | +255.8% ▲ |
| Terbinafine hydrochloride | 50 | 1,635 | £297 | +34.8% ▲ |
| 50 | 5,780 | £823 | +57.5% ▲ | |
| Glyceryl trinitrate | 48 | 1,440 | £1.8K | +261.3% ▲ |
| Desloratadine | 48 | 3,256 | £298 | +66.4% ▲ |
| 48 | 2,520 | £5.4K | +356.8% ▲ | |
| Co-tenidone (Atenolol/chlortalidone) | 47 | 1,036 | £247 | +125.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.